Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.
Acc Chem Res. 2022 Dec 6;55(23):3481-3494. doi: 10.1021/acs.accounts.2c00607. Epub 2022 Nov 22.
The development of palladium-catalyzed cross-coupling methods for the activation of C(sp)-Br bonds facilitated access to arene-rich molecules, enabling a concomitant increase in the prevalence of this structural motif in drug molecules in recent decades. Today, there is a growing appreciation of the value of incorporating saturated C(sp)-rich scaffolds into pharmaceutically active molecules as a means to achieve improved solubility and physiological stability, providing the impetus to develop new coupling strategies to access these challenging motifs in the most straightforward way possible. As an alternative to classical two-electron chemistry, redox chemistry can enable access to elusive transformations, most recently, by interfacing abundant first-row transition-metal catalysis with photoredox catalysis. As such, the functionalization of ubiquitous and versatile functional handles such as (aliphatic) carboxylic acids via metallaphotoredox catalysis has emerged as a valuable field of research over the past eight years.In this Account, we will outline recent progress in the development of methodologies that employ aliphatic and (hetero)aromatic carboxylic acids as adaptive functional groups. Whereas recent decarboxylative functionalization methodologies often necessitate preactivated aliphatic carboxylic acids in the form of redox-active esters or as ligands for hypervalent iodine reagents, methods that enable the direct use of the native carboxylic acid functionality are highly desired and have been accomplished through metallaphotoredox protocols. As such, we found that bench-stable aliphatic carboxylic acids can undergo diverse transformations, such as alkylation, arylation, amination, and trifluoromethylation, by leveraging metallaphotoredox catalysis with prevalent first-row transition metals such as nickel and copper. Likewise, abundant aryl carboxylic acids are now able to undergo halogenation and borylation, enabling new entry points for traditional, primarily palladium- or copper-catalyzed cross-coupling strategies. Given the breadth of the functional group tolerance of the employed reaction conditions, the late-stage functionalization of abundant carboxylic acids toward desired targets has become a standard tool in reaction design, enabling the synthesis of various diversified drug molecules. The rapid rise of this field has positively inspired pharmaceutical discovery and will be further accelerated by novel reaction development. The achievement of generality through reaction optimization campaigns allows for future breakthroughs that can render protocols more reliable and applicable for industry. This article is intended to highlight, in particular, (i) the employment of aliphatic and (hetero)aryl carboxylic acids as powerful late-stage adaptive functional handles in drug discovery and (ii) the need for the further development of still-elusive and selective transformations.We strongly believe that access to native functionalities such as carboxylic acids as adaptive handles will further inspire researchers across the world to investigate new methodologies for complex molecular targets.
钯催化交叉偶联方法的发展促进了 C(sp)-Br 键的活化,使芳族丰富的分子更容易获得,这使得这种结构基序在最近几十年的药物分子中更为普遍。如今,人们越来越认识到将富含饱和 C(sp)的支架纳入具有生物活性的分子中的价值,这是提高药物溶解度和生理稳定性的一种手段,这也推动了开发新的偶联策略,以尽可能直接地获得这些具有挑战性的结构基序。作为经典两电子化学的替代方法,氧化还原化学可以实现难以捉摸的转化,最近,通过界面丰富的第一过渡金属催化与光氧化还原催化相结合实现了这一转化。因此,通过金属光氧化还原催化对普遍存在且多功能的官能团(如(脂肪族)羧酸)进行功能化,已成为过去八年中一个有价值的研究领域。在本综述中,我们将概述最近在开发利用脂肪族和(杂)芳族羧酸作为适应性官能团的方法方面的进展。虽然最近的脱羧官能化方法通常需要以氧化还原活性酯或高价碘试剂的配体形式预先激活脂肪族羧酸,但人们非常希望能够直接使用天然羧酸官能团,这已经通过金属光氧化还原协议实现了。因此,我们发现通过利用镍和铜等常见的第一过渡金属的金属光氧化还原催化,可以使稳定的脂肪族羧酸发生各种转化,如烷基化、芳基化、氨基化和三氟甲基化。同样,丰富的芳基羧酸现在也能够进行卤化和硼化,为传统的主要基于钯或铜的交叉偶联策略提供了新的切入点。鉴于所采用反应条件对官能团的广泛耐受性,将丰富的羧酸进行后期官能化以得到所需的目标产物已成为反应设计中的一种标准工具,这使得各种多样化的药物分子的合成成为可能。该领域的快速发展极大地激发了药物发现,并将通过新的反应开发进一步加速。通过反应优化方案实现通用性,为未来的突破提供了可能,使这些方案更可靠、更适用于工业界。本文特别强调了(i)将脂肪族和(杂)芳基羧酸用作药物发现中强大的后期适应性官能团,以及(ii)进一步开发仍然难以捉摸和选择性的转化的必要性。我们坚信,获得羧酸等天然官能团作为适应性配体将进一步激发全球研究人员探索用于复杂分子靶标的新方法。